Literature DB >> 33618364

Reimagining external beam radiotherapy for glioblastoma: "old beam, new trick".

Peter Mathen1, DeeDee K Smart1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33618364      PMCID： PMC7992895          DOI： 10.1093/neuonc/noab008

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   12.300


× No keyword cloud information.
  8 in total

1.  Reirradiation of glioblastoma through the use of a reduced dose rate on a tomotherapy unit.

Authors:  Karl H Rasmussen; Nicholas Hardcastle; Steven P Howard; Wolfgang A Tomé
Journal:  Technol Cancer Res Treat       Date:  2010-08

2.  Tissue repair and repopulation in the tumor bed effect.

Authors:  N H Terry; K K Ang; N R Hunter; L Milas
Journal:  Radiat Res       Date:  1988-06       Impact factor: 2.841

3.  Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.

Authors:  Roger Stupp; Warren P Mason; Martin J van den Bent; Michael Weller; Barbara Fisher; Martin J B Taphoorn; Karl Belanger; Alba A Brandes; Christine Marosi; Ulrich Bogdahn; Jürgen Curschmann; Robert C Janzer; Samuel K Ludwin; Thierry Gorlia; Anouk Allgeier; Denis Lacombe; J Gregory Cairncross; Elizabeth Eisenhauer; René O Mirimanoff
Journal:  N Engl J Med       Date:  2005-03-10       Impact factor: 91.245

4.  Radiation-induced dementia in patients cured of brain metastases.

Authors:  L M DeAngelis; J Y Delattre; J B Posner
Journal:  Neurology       Date:  1989-06       Impact factor: 9.910

5.  Transition in survival from low-dose hyper-radiosensitivity to increased radioresistance is independent of activation of ATM Ser1981 activity.

Authors:  Sarah A Krueger; Spencer J Collis; Michael C Joiner; George D Wilson; Brian Marples
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-11-15       Impact factor: 7.038

6.  Net clinical benefit analysis of radiation therapy oncology group 0525: a phase III trial comparing conventional adjuvant temozolomide with dose-intensive temozolomide in patients with newly diagnosed glioblastoma.

Authors:  Terri S Armstrong; Jeffrey S Wefel; Meihua Wang; Mark R Gilbert; Minhee Won; Andrew Bottomley; Tito R Mendoza; Corneel Coens; Maria Werner-Wasik; David G Brachman; Ali K Choucair; Minesh Mehta
Journal:  J Clin Oncol       Date:  2013-10-07       Impact factor: 44.544

7.  Phase I three-dimensional conformal radiation dose escalation study in newly diagnosed glioblastoma: Radiation Therapy Oncology Group Trial 98-03.

Authors:  Christina Tsien; Jennifer Moughan; Jeff M Michalski; Mark R Gilbert; James Purdy; Joseph Simpson; John J Kresel; Walter J Curran; Aidnag Diaz; Minesh P Mehta
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-08-23       Impact factor: 7.038

8.  Pulsed reduced dose-rate radiotherapy: case report : a novel re-treatment strategy in the management of recurrent glioblastoma multiforme.

Authors:  George M Cannon; Wolfgang A Tomé; H Ian Robins; Steven P Howard
Journal:  J Neurooncol       Date:  2007-01-25       Impact factor: 4.506
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.